← All trials
NCT06886230
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 20, 2025
- Primary completion
- Jun 10, 2025
- Completion date
- Jun 11, 2025
- First posted
- Mar 20, 2025
- Last posted
- Jun 17, 2025
- Enrollment
- 105
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Lahore Medical and Dental collegeLead sponsor
- Lahore Medical and Dental collegeCollaborator
- Lahore Medical and Dental collegeOfficial
- Lahore Medical and Dental collegeSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.